GlassScriptPhysician profile
T K Venkatesan
NPI 1295797470
$793.52
in general payments reported to CMS, 2019-2025
20 companies · $77.76 in 2025
The $77.76 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2021: $173 · 2022: $233 · 2023: $145 · 2024: $48.56 · 2025: $77.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $237.12 | 2019-2022 | |
| Glaxosmithkline, LLC. | $102.53 | 2021-2022 | |
| Smith+Nephew, INC. | $76.04 | 2022-2023 | Tula, Coblation |
| Inspire Medical Systems, INC. | $54.49 | 2023-2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $36.69 | 2019-2021 | |
| Ethicon US, LLC | $35.76 | 2025 | Harmonic |
| Stryker Corporation | $28.60 | 2019 | |
| Fisher & Paykel Healthcare INC | $23.56 | 2024 | Fisher & Paykel Healthcare |
| Aerin Medical INC. | $23.41 | 2025 | |
| Cook Medical LLC | $22.55 | 2019 | |
| Hospira, INC. | $22.19 | 2019 | |
| Genzyme Corporation | $22.19 | 2023 | |
| Merck Sharp & Dohme LLC | $22.04 | 2023 | |
| Hikma Pharmaceuticals USA | $19.70 | 2023 | Ryaltris |
| Amgen INC. | $18.59 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $18.05 | 2021 | |
| Optinose US, INC. | $16.62 | 2019 | |
| Bolder Surgical LLC | $13.39 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw T K Venkatesan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.